Role of eicosanoids of the contralateral kidney in maintenance of two-kidney, one-clip renovascular hypertension in rats.
OBJECTIVE
To elucidate the role of the eicosanoids prostaglandin E(2) (PGE(2)), 6-keto-prostaglandin F(1a) (PGF(1a)) and thromboxane B(2) (TXB(2)) in the maintenance of two-kidney, one-clip renovascular hypertension in rats.


METHODS
The right renal artery was constricted by a silver clip in 63 male Sprague-Dawley rats to induce hypertension, while a sham operation was performed in 17 control rats. Six months after the induction of hypertension, nephrectomy of the clipped kidney was performed. Nephrectomy was followed by a period of high sodium intake. Blood pressure and eicosanoid excretion were measured before and after nephrectomy of the clipped kidney, as well as during high sodium intake.


RESULTS
During the chronic phase of Goldblatt hypertension, the amount of vasoconstrictive TXB(2) excreted by the contralateral kidney increased compared to that in the controls, whereas PGE(2) excretion was unaffected. Eicosanoid excretion before and after removal of the clipped kidney did not differ between post-Goldblatt hypertensive and post-Goldblatt normotensive animals. During the period of high sodium intake, PGE(2) excretion increased only in control rats, being unaltered in Goldblatt hypertensive rats.


CONCLUSIONS
In the chronic phase of two-kidney, one-clip renovascular hypertension, the contralateral kidney of post-Goldblatt hypertensive and post-Goldblatt normotensive rats excretes more vasoconstrictive thromboxane in comparison to controls, whereas excretion of vasodilatory prostaglandin is not elevated. However, increased TXB(2) excretion and the absence of an increase in PGE(2) excretion from the contralateral kidney do not appear to be important for the maintenance of high blood pressure in this model of renovascular hypertension.
Kalaitzis
Christos
C
Departments of Urology, University of Thrace, Alexandroupolis, Greece. chkalaitzis@hotmail.com
Giannakopoulos
Stilianos
S
Pantazis
Thrasyboulos
T
Pasadakis
Ploumis
P
Touloupidis
Stavros
S
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D015232:Dinoprostone / Q000494:pharmacology; D015777:Eicosanoids / Q000494:pharmacology*; D006978:Hypertension, Renovascular / Q000139:chemically induced / Q000473:pathology*; D007668:Kidney / Q000187:drug effects* / Q000473:pathology*; D008297:Male; D009392:Nephrectomy; D011460:Prostaglandins F / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012982:Sodium, Dietary; D013929:Thromboxane B2 / Q000494:pharmacology
D015777:Eicosanoids; D011460:Prostaglandins F; D012982:Sodium, Dietary; D013929:Thromboxane B2; D015232:Dinoprostone; C100006:prostaglandin F1